United States · FDA National Drug Code directory
tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72578-097_8fd84300-3ed6-42ff-b20c-608ea5dc96eb
- Product NDC
- 72578-097
- Form
- TABLET
- Composition / generic term
- tizanidine
- Labeler
- Viona Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210304
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (72578-097-06) · 72578-097-06
- 1000 TABLET in 1 BOTTLE (72578-097-10) · 72578-097-10
- 150 TABLET in 1 BOTTLE (72578-097-21) · 72578-097-21
- 300 TABLET in 1 BOTTLE (72578-097-76) · 72578-097-76
- 10 BLISTER PACK in 1 CARTON (72578-097-77) / 10 TABLET in 1 BLISTER PACK (72578-097-30) · 72578-097-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →